
---
title: '海外New Things _「Nimbus Therapeutics」获1.25亿美元融资，推进TYK2抑制剂等候选药物临床试验'
categories: 
 - 新媒体
 - 36kr
 - 资讯
headimg: 'https://picsum.photos/400/300?random=2737'
author: 36kr
comments: false
date: Thu, 15 Sep 2022 08:13:42 GMT
thumbnail: 'https://picsum.photos/400/300?random=2737'
---

<div>   
海外New Things |「Nimbus Therapeutics」获1.25亿美元融资，推进TYK2抑制剂等候选药物临床试验  
</div>
            